FMC Technologies (FTI) Reports Q1 Earnings: What Key Metrics Have to Say
Werte in diesem Artikel
FMC Technologies (FTI) reported $2.23 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 9.4%. EPS of $0.33 for the same period compares to $0.22 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $2.26 billion, representing a surprise of -1.07%. The company delivered an EPS surprise of -8.33%, with the consensus EPS estimate being $0.36.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how FMC Technologies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Inbound Orders - Subsea Technologies: $2.79 billion compared to the $2.47 billion average estimate based on 15 analysts. Order Backlog - Subsea Technologies: $14.95 billion compared to the $14.06 billion average estimate based on 15 analysts. Order Backlog - Total: $15.82 billion versus $14.98 billion estimated by 14 analysts on average. Inbound Orders - Total: $3.09 billion versus $2.78 billion estimated by 14 analysts on average. Order Backlog - Surface Technologies: $870.40 million compared to the $909.26 million average estimate based on 13 analysts. Inbound Orders - Surface Technologies: $303.60 million compared to the $317.59 million average estimate based on 13 analysts. Book-to-bill - Subsea: 1 versus 1 estimated by 13 analysts on average. Revenue- Subsea Technologies: $1.94 billion versus the 18-analyst average estimate of $1.96 billion. The reported number represents a year-over-year change of +11.6%. Revenue- Surface Technologies: $297.40 million versus the 18-analyst average estimate of $290.59 million. The reported number represents a year-over-year change of -3.2%. Revenue- Lease: $61.40 million versus the three-analyst average estimate of $59.31 million. The reported number represents a year-over-year change of -1.4%. Revenue- Product: $868.20 million versus $785.57 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +6.7% change. Revenue- Service: $1.30 billion compared to the $1.41 billion average estimate based on three analysts. The reported number represents a change of +11.9% year over year. View all Key Company Metrics for FMC Technologies here>>>Shares of FMC Technologies have returned -18.7% over the past month versus the Zacks S&P 500 composite's -5.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report TechnipFMC plc (FTI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf FMC
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Fresenius Medical Care (FMC) St.
Analysen zu Fresenius Medical Care (FMC) St.
Datum | Rating | Analyst | |
---|---|---|---|
23.04.2025 | Fresenius Medical Care (FMC) St Neutral | UBS AG | |
23.04.2025 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. | |
22.04.2025 | Fresenius Medical Care (FMC) St Hold | Deutsche Bank AG | |
22.04.2025 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.04.2025 | Fresenius Medical Care (FMC) St Equal Weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
23.04.2025 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. | |
22.04.2025 | Fresenius Medical Care (FMC) St Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.03.2025 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. | |
27.02.2025 | Fresenius Medical Care (FMC) St Kaufen | DZ BANK | |
25.02.2025 | Fresenius Medical Care (FMC) St Buy | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
23.04.2025 | Fresenius Medical Care (FMC) St Neutral | UBS AG | |
22.04.2025 | Fresenius Medical Care (FMC) St Hold | Deutsche Bank AG | |
22.04.2025 | Fresenius Medical Care (FMC) St Equal Weight | Barclays Capital | |
16.04.2025 | Fresenius Medical Care (FMC) St Market-Perform | Bernstein Research | |
04.03.2025 | Fresenius Medical Care (FMC) St Market-Perform | Bernstein Research |
Datum | Rating | Analyst | |
---|---|---|---|
17.04.2025 | Fresenius Medical Care (FMC) St Underweight | JP Morgan Chase & Co. | |
21.03.2025 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. | |
04.03.2025 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. | |
26.02.2025 | Fresenius Medical Care (FMC) St Underweight | JP Morgan Chase & Co. | |
25.02.2025 | Fresenius Medical Care (FMC) St Underperform | Jefferies & Company Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen